Captozyme

Captozyme is a preclinical stage biotechnology company dedicated to the enhancement of foods to reduce intake of oxalate.

Founded

2009

Raised

$3.4M

Follow us

Companies in the same industry

Alexa global traffic share

Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

15 Mar 2017

$3,400,000

Venture capital (Series A)